Nombre del producto |
N2-[[(1-carboxifenetil)amino]carbonil]-L-arginil-N-[4-[(aminoiminometil)amino]-1-formilbutil]-L-valinamida |
Sinónimos |
Antidolor; CCRIS 3605; L-Valinamida, N(sup 2)-(((1-carboxi-2-feniletil)amino)carbonilo)-L-arginil-N-(4-((aminoiminometil)amino)-1-formilbutilo)-; L-Valinamida N2-(((1-carboxi-2-feniletil)amino)carbonil)-L-arginil-N-(4-((aminoiminometil)amino)-1-formilbutilo)-; N2-(((1-carboxifenetil)amino)carbonil)-L-arginil-N-(4-((aminoiminometil)amino)-1-formilbutil)-L-valinamida; N~2~-{[(1S)-1-carboxi-2-feniletil]carbamoil}-N~5~-(diaminometilideno)-L-ornitil-N-{(2S)-5-[(diaminometilideno)amino]-1-oxopentan-2-il}-L-valinamida |
Nombre en inglés |
N2-[[(1-carboxyphenethyl)amino]carbonyl]-L-arginyl-N-[4-[(aminoiminomethyl)amino]-1-formylbutyl]-L-valinamide;Antipain; CCRIS 3605; L-Valinamide, N(sup 2)-(((1-carboxy-2-phenylethyl)amino)carbonyl)-L-arginyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-; L-Valinamide, N2-(((1-carboxy-2-phenylethyl)amino)carbonyl)-L-arginyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-; N2-(((1-Carboxyphenethyl)amino)carbonyl)-L-arginyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-L-valinamide; N~2~-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-N~5~-(diaminomethylidene)-L-ornithyl-N-{(2S)-5-[(diaminomethylidene)amino]-1-oxopentan-2-yl}-L-valinamide |
Fórmula molecular |
C27H44N10O6 |
Peso Molecular |
604.7017 |
InChI |
InChI=1/C27H44N10O6/c1-16(2)21(23(40)34-18(15-38)10-6-12-32-25(28)29)37-22(39)19(11-7-13-33-26(30)31)35-27(43)36-20(24(41)42)14-17-8-4-3-5-9-17/h3-5,8-9,15-16,18-21H,6-7,10-14H2,1-2H3,(H,34,40)(H,37,39)(H,41,42)(H4,28,29,32)(H4,30,31,33)(H2,35,36,43)/t18-,19-,20-,21-/m0/s1 |
Número de registro CAS |
37691-11-5 |
EINECS |
253-631-0 |
Estructura Molecular |
|
Densidad |
1.38g/cm3 |
Índice de refracción |
1.631 |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|